Q1 2015

Source filing unavailable

Q1 2015 · —

Revenue—

Net Income

-$2.62M

N/M vs Q1 2014

EPS Diluted

-$1.61

N/M vs Q1 2014

Operating Income-$2,629,000—

Operating Cash Flow-$2,802,000—

Free Cash Flowderived-$2,879,000—

Same quarter

Metric	Q1 2015	Q1 2014
Net Income	-$2.62M	-$1.03M
EPS Diluted	-$1.61	-$0.95

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Aclaris Therapeutics, Inc. · CIK 1557746 · Engraved from SEC EDGAR